February 18th, 2015
•Tumor-initiating cells (TICs) may represent a viable therapeutic target for the treatment of ovarian cancer, a highly recurrent and fatal disease. We present a protocol for culture conditions that enrich for this highly tumorigenic population of cells.
Videos relacionados
In vitro Mesothelial Clearance Assay that Models the Early Steps of Ovarian Cancer Metastasis
Heterotypic Three-dimensional In Vitro Modeling of Stromal-Epithelial Interactions During Ovarian Cancer Initiation and Progression
Label-free Isolation and Enrichment of Cells Through Contactless Dielectrophoresis
Profiling of Estrogen-regulated MicroRNAs in Breast Cancer Cells
Method for Obtaining Primary Ovarian Cancer Cells From Solid Specimens
Assessment of Ovarian Cancer Spheroid Attachment and Invasion of Mesothelial Cells in Real Time
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Enrichment for Chemoresistant Ovarian Cancer Stem Cells from Human Cell Lines
Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
In Vivo and Ex Vivo Approaches to Study Ovarian Cancer Metastatic Colonization of Milky Spot Structures in Peritoneal Adipose
ACERCA DE JoVE
Copyright © 2024 MyJoVE Corporation. Todos los derechos reservados